AskBio to Present New Gene Therapy and AAV Manufacturing Research at ASGCT 2026 AskBio, a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has announced that it will present six scientific sessions at the…
Altasciences and Certara Form Strategic Partnership to Advance Model-Informed Drug Development Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development through the integration of model-informed drug development technologies, biosimulation tools, and fully integrated research services.…
Rocket Pharmaceuticals Reports First Quarter 2026 Results and Advances Cardiovascular Gene Therapy Pipeline Rocket Pharmaceuticals, a commercial-stage biotechnology company focused on developing genetic therapies for rare and life-threatening disorders, has announced its financial and operational results for the first quarter…
Seek Labs Secures U.S. Patent for Innovative Isothermal Amplification Technology Designed to Advance Decentralized Molecular Diagnostics Seek Labs, a private TechBio company focused on building programmable platforms to decode, program, and resolve diseases, has announced that the United States Patent…
CareQuest Innovation Partners and PDS Health Join Forces to Expand Blood Pressure Screening in Dental Settings, Advancing Integrated Care Delivery CareQuest Innovation Partners and PDS Health have announced a new initiative aimed at expanding blood pressure screening and patient consultation…
VectorBuilder Granted European Patent for MiniVec™, a Plasmid Backbone Enhancing Safety and Scalable Manufacturing in Genetic Medicine VectorBuilder, a global provider of gene delivery technologies and contract development and manufacturing (CDMO) services, has announced a significant advancement in its innovation…
New Study Demonstrates Sensome’s Clot-Sensing Guidewire Precisely Identifies Clot Composition in Fully Occluded Brain Vessels for the First Time Sensome, a biotechnology innovator specializing in microsensing technology for real-time intra-operative tissue analysis, has announced the publication of groundbreaking first-in-human results…
J&J Highlights FDA Approval of STELARA® for Pediatric Crohn’s Disease The U.S. Food and Drug Administration (FDA) has approved STELARA (ustekinumab) for the treatment of pediatric patients aged two years and older with moderately to severely active Crohn’s disease (CD).…
Outfront Health Names Dr. Shane Speirs as Chief Medical Officer Outfront Health has announced the appointment of Shane Speirs, MD, MBA, as its new Chief Medical Officer (CMO), a strategic leadership move aimed at strengthening the company’s clinical direction and…
FDA Advisory Committee Backs TRUQAP® (capivasertib) for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee has delivered a largely favorable assessment of TRUQAP, an investigational targeted therapy developed by AstraZeneca, when used in…
Contineum Therapeutics Announces Encouraging Topline Results from Exploratory Phase 1b Study of PIPE-791 in Chronic Pain Contineum Therapeutics, Inc. (NASDAQ: CTNM), a clinical-stage biopharmaceutical company focused on advancing differentiated therapies across neuroscience, inflammation, and immunology (NI&I) indications, has announced encouraging…
TRexBio Initiates Phase 1b Study of TRB-061 in Moderate-to-Severe Atopic Dermatitis with First Patient Dosed TRex Bio, Inc. (“TRexBio”), a clinical-stage biotechnology company focused on discovering and developing immunoregulatory therapies rooted in tissue regulatory T cell (Treg) biology, has announced…